Results
UBS Series Funds
07/06/2026 | Press release | Distributed by Public on 07/06/2026 15:00
Iran Notice (Form IRANNOTICE)
UBS Series Funds
c/o UBS Asset Management
1285 Avenue of the Americas
New York, NY 10019-6064
July 6, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that UBS Series Funds has made disclosure pursuant to such provisions in its Annual Report on Form N-CSR for the fiscal year ended April 30, 2026, which was filed with the U.S. Securities and Exchange Commission on July 6, 2026.
| Very truly yours, | ||
| UBS Series Funds | ||
| By: | /s/ Rose Ann Bubloski | |
| Name: | Rose Ann Bubloski | |
| Title: | Principal Financial Officer | |
UBS Series Funds published this content on July 06, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 06, 2026 at 21:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]